Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Donate

Donate to Embrace Mental health is a major and complex issue impacting our children and young people, but it is still not fully understood. That’s

Tell us your thoughts

Embrace is always looking to our community group for new ideas on how to better connect with you. Let us know what events and topics you would like to see for a chance to win 1 of 3 $50 vouchers!

Research

Changes in the clinical and epidemiological features of group A streptococcal bacteraemia in Australia's northern territory

We aimed to measure the incidence and severity of invasive Group A Strep disease in the NT since 1996.

Research

Dendritic cells and multiple sclerosis: Disease, tolerance and therapy

Multiple sclerosis (MS) is a devastating neurological disease that predominantly affects young adults resulting in severe personal and economic impact.

Research

Childhood and parental diagnostic radiological procedures and risk of childhood brain tumors

We found no evidence of positive associations between risk of childhood brain tumours overall and childhood or parental pre-pregnancy radiological procedures.

Research

Respiratory Syncytial Virus (RSV)

RSV hospitalises millions of babies worldwide every year: our research is helping to change that.

COVID-19 Resource Hub

While COVID-19 is new and frightening, these resources are designed to help families tackle the challenges this virus has created for us.

Research

Autism

Characterised by varying degrees of difficulties in communication skills and social abilities, one in every 100 individuals will have a diagnosis of an autism spectrum condition. While autism is known to run in families, the exact causes remain unknown.

Research

Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency Disorder

CDKL5 deficiency disorder (CDD) is a rare developmental and epileptic encephalopathy (DEE) associated with multiple impairments and comorbidities. Outcome measures for disease-modifying clinical trials for DEEs should measurably capture a spectrum of caregiver priorities and be externally validated.

Research

Convalescent plasma in hospitalised patients with COVID-19

Convalscent plasma (CP) was identified as a potential therapy for COVID-19 available early in the pandemic.